Skip to main content
Home > Conferences > BioEquity Europe > Dates, Location & Schedules > Presenting Companies Schedule
BioCentury Conference Center

Bio€quity Europe 2015 Conference Agenda

Monday, May 18
19:00 - 21:00

Welcome Networking Reception at Kursalon Vienna
The Kursalon Vienna is located opposite the InterContinental hotel (150 meters). Please pick up your name badge at our registration desk in the hotel lobby. It is open 18:30—21:00.

Kursalon Vienna
Johannesgasse 33
1010 Vienna

We gratefully acknowledge the support of
ABG Sundal Collier

Tuesday, May 19
07:45 - 09:30 Registration Opens and Breakfast (Foyer Level 1)
09:00 - 09:30

Welcome and Official Greeting from the Organizers and Regional Hosts (Ballroom 1, 2 & 3)
David Flores, Co-Founder, President & CEO, BioCentury
Pam Putz, Managing Director, EBD Group
Harald Mahrer, State Secretary, Federal Ministry of Science, Research and Economics
Gerhard Hirczi, Managing Director, Vienna Business Agency
David Thomas, Director, Industry Research & Analysis, Biotechnology Industry Organization (BIO)

09:30 - 10:30

The 8th Annual BioCentury/EY Face-Off
(Ballroom 1, 2 & 3)

Dr. Siegfried Bialojan, Executive Director, Head European Life Science Center, EY
Susan Schaeffer, Editor, BioCentury
Roel Bulthuis, Head, MS Ventures
Antoine Papiernik, Managing Partner, Sofinnova Partners
Paul Tomasic, Managing Director, RBC Capital Markets
10:30 - 11:00 Coffee / Networking Break
11:00 - 12:00

Plenary 1 - Downstream Innovation Scorecard: Can Europe Stay Ahead of the Pack?
(Ballroom 1)

In this opening session key stakeholders will discuss where European companies stand on global corporate development and strategic growth initiatives such as financing and exit strategies, especially those involving the U.S. market. This plenary session will also explore where Europe stands on regulatory and policy innovation, and whether Europe's innovations and companies have global visibility.

Dr. Frank Kalkbrenner, Vice President, Boehringer Ingelheim Venture Fund (Moderator)
James Gubbins, Partner, Covington & Burling
Paul Hadden, Principal, HealthCare Royalty Partners
Dr. Michèle Ollier, Partner, Index Ventures
Graziano Seghezzi, Partner, Sofinnova Partners

Plenary 2 - Upstream Innovation Scorecard
(Ballroom 2)

This parallel opening session will focus on the state of European innovation in the earliest parts of drug discovery and development. Key stakeholders will debate where Europe stands on innovative basic science and on the ability to source that science for translation into the corporate setting. Panelists include:

Dr. Simone Fishburn, Editor, BioCentury Innovations, BioCentury (Moderator)
Dr. Jeanne Bolger, Vice President of Venture Investments, Johnson & Johnson
Dr. Francesco de Rubertis, Managing Partner, Index Ventures
Dr. Werner Lanthaler, CEO, Evotec
Dr. Henrijette Richter, Partner, Sofinnova Partners
Dr. David Tapolczay, CEO, MRC Technology

LISAVienna Regional Host Showcase and Workshop
(Ballroom 3)

Presenting Companies:
EveliQure Biotechnologies GmbH
Lacerta Technologies GmbH
ORIGIMM Biotechnology GmbH
Panoptes Pharma Ges.m.b.H
ViraTherapeutics GmbH

12:00 - 14:00 Lunch and Networking Time (Vier Jahreszeitn)

Presentation Rooms

Ballroom 1 Ballroom 2 Ballroom 3 Salon Schubert + Lehar
14:00 - 14:20 Molecular Partners AG (SIX:MOLN) uniQure N.V. (NASDAQ:QURE)

CEO Boot camp #6
Managing Your Board
(14:00 - 15:15)

For a sixth year, Bio€quity Europe provides core lessons for biotech CEOs and their investors. This year's discussion aims to provide critical insight to the C-suite of young companies on how to manage your board of directors. Panelists include:

Dr. Carole Nuechterlein, Head, Roche Venture Fund (Moderator)
Tim Dyer, CEO, Addex
Dr. Deborah Harland, Partner, SROne
Dr. Genghis Lloyd-Harris, Partner, Abingworth
Dr. Allan Marchington, Partner, Apposite Capital

Next Wave Company Presentations

Histide AG
Acousia Therapeutics GmbH
Allecra Therapeutics GmbH
Wilson Therapeutics AB
eTheRNA N.V.
Metys Pharmaceuticals AG
Novithera Ltd.
Mission Therapeutics Ltd.
Amal Therapeutics S.A.
Numab AG
IO Biotech ApS
Netris Pharma S.A.S.
Inivata Ltd.
Xenikos B.V.
Prexton Therapeutics S.A.
Activartis Biotech GmbH

14:20 - 14:40

4SC AG (Xetra:VSC) Cell Therapy Ltd.
14:40 - 15:00 Apogenix GmbH Hookipa Biotech AG
15:00 - 15:20 Evotec AG (Xetra:EVT) Vaximm AG
15:20 - 15:40 Atlas Genetics Ltd. Silence Therapeutics plc (LSE:SLN)

Divining Fact From Fiction
(15:30 - 16:40)

Investor Litmus Test on Hot Spaces including gene therapy; CAR-T, Orphan and others ...
Panelists include:

Dr. Joep Muijrers, LSP (Moderator)
Jörn Aldag, CEO, uniQure
Dr. Andre Choulika, Chairman and CEO, Cellectis
Dr. Hakan Goker, Investment Director, MS Ventures
Dr. Otello Stampacchia, Managing Director, Omega Funds
Kurt von Emster, Partner, Abingworth
15:40 - 16:00 Probiodrug AG (Euronext:PBD) Poxel S.A. (Euronext:POXEL)
16:00 - 16:20 Affimed N.V. (NASDAQ:AFMD) Biomay AG
16:20 - 16:40 Auris Medical Holding AG (NASDAQ:EARS) PsiOxus Therapeutics Ltd.
16:40 - 17:00 KineMed Inc. Abzena plc (LSE:ABZA) Medigene AG (Xetra:MDG1)  
17:00 - 17:20 Nanobiotix S.A. (Euronext:NANO) Erytech Pharma S.A. (Euronext:ERYP) Chamaeleo Pharma N.V.

Next Wave Company Presentations

Recardio GmbH
Sulfagenix Inc.
Inflection Biosciences Ltd.
Elasmogen Ltd
Ossianix Inc.

17:20 - 17:40 MorphoSys AG (Xetra:MOR; Pink:MPSYF) Kiadis Pharma B.V. Mologen AG (Xetra:MGN)
17:40 - 18:00 CureVac GmbH Advanced Accelerator Applications S.A. Serodus ASA (OSE:SER)
18:00 - 18:30 Transportation to Networking Reception and Dinner
A short guided bus tour following Vienna’s famous Ringstrasse (ring boulevard), which also celebrates its 150th anniversary this year, will transport guests to the evening event. You will see some of the city’s most historical sites: Vienna State Opera - Hofburg Palace - Museum of Art History - Museum of Natural History - Volksgarten - Austrian Parliament – Town Hall - Burgtheater – University of Vienna
18:30 - 22:30

Networking Reception and Dinner
Palais Ferstel
Freyung 2
1010 Vienna, Austria

Hosted by
ABG Sundal Collier

Wednesday, May 20
07:45 - 09:30 Registration Opens and Breakfast (Foyer Level 1)

Presentation Rooms

Ballroom 1 Ballroom 2 Ballroom 3 Salon Schubert + Lehar
09:00 - 09:20 Epigenomics AG (Xetra:ECX; OTCQX:EPGNY) Valneva SE (Euronext:VLA; VSE:VLA)

Fireside Chats: War Stories from Those Who Adapted


Bio€quity Europe continues its tradition of intimate Q&A sessions, this year offering lessons from CEOs who have managed their way through challenging times. Panelists include:

Neil Mackison, Managing Director, Piper Jaffray (Moderator)
Peter Llewellyn-Davies,
, MediGene
Enno Spillner,
, 4SC
Stefan Weber,
, Newron

Next Wave Company Presentations

MiNA Therapeutics Ltd.
Rigontec GmbH
Asceneuron S.A.
MedinCell S.A.
Cristal Therapeutics
TocopheRx Inc.
Lipopharma Therapeutics S.L.
Abionic S.A.
Eternygen GmbH
Amphera B.V.
Inventiva S.A.S.
Minoryx Therapeutics S.L.
GamaMabs Pharma S.A.
PDC*line Pharma
BerGenBio A/S
Regenesance B.V.
PolyPid Ltd.

09:20 - 09:40 Addex Therapeutics Ltd. (SIX:ADXN) MolMed S.p.A. (Milan:MLM)
09:40 - 10:00 Transgene S.A. (Euronext:TNG) BioLineRx Ltd. (Tel Aviv:BLRX; NASDAQ:BLRX)
10:00 - 10:20 Apitope International N.V. Anergis S.A.

Ernst & Young - Beyond Borders Breakout Session

Jürg Zürcher, Partner, EMEIA Biotechnology Leader at EY, and other members of EY's European life science team present their analysis of the European IPO markets and discuss whether strength will continue.

10:20 - 10:40 Spinifex Pharmaceuticals Pty. Ltd. Humabs BioMed S.A.
10:40 - 11:00   AFFiRiS AG
11:00 - 11:20 Ascendis Pharma A/S (NASDAQ:ASND) Piqur Therapeutics AG
11:20 - 11:40 Opsona Therapeutics Ltd. Merus B.V.

The China Bridge - How Europe is Amplifying its Innovation through China Deal-Making

Dr. Debra Yu, Managing Director, Labrador Advisors (Moderator)
Robert Braithwaite, Chairman and CEO, Luqa Pharmaceuticals
Dr. Benjamin Li,, CEO, Lee's Pharma
Dr. Mirko Scherer, Managing Partner, TVM Capital
Dr. Xiaoming Zou, CBO Eddingpharm
11:40 - 12:00 Newron Pharmaceuticals S.p.A. (SIX:NWRN) AM-Pharma B.V.
12:00 - 12:20 Complix N.V.  Midatech Pharma plc (LSE:MTPH)
12:20 - 12:40 Genticel S.A. (Euronext:GTCL) Nuevolution A/S
12:30 - 14:00 Lunch and Networking Time
14:00 - 14:20      
14:20 - 14:40 Neovacs S.A. (Euronext:ALNEV) Aposcience AG
14:40 - 15:00 SynAffix B.V. Abivax S.A.S.
15:00 - 15:20 Motif Bio plc (LSE:MTFB)  
15:30 - 16:00

Networking Closing Reception and Regional Host Handoff
LISAVienna and the 2016 Regional Hosts